| Clinical chemosensitization by misonidazole and related compounds: a critical evaluation |
| RT Mulcahy and DL Trump |
|
JCO Apr 1 1988: 569–573.
[PDF]
|
 |
| Exploratory laparotomy and splenectomy for Hodgkin's disease: a commentary |
| SA Rosenberg |
|
JCO Apr 1 1988: 574–575.
[PDF]
|
|
|
High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia |
| |
S Riddell, FR Appelbaum, CD Buckner, P Stewart, R Clift, J Sanders, R Storb, K Sullivan, and ED Thomas |
| |
JCO Apr 1 1988: 576–582.
[Abstract]
[PDF]
|
|
|
Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia |
| |
PA Cassileth, DP Harrington, JD Hines, MM Oken, JJ Mazza, P McGlave, JM Bennett, and MJ O'Connell |
| |
JCO Apr 1 1988: 583–587.
[Abstract]
[PDF]
|
|
|
Reproductive and endocrine gonadal functions in adults following multidrug chemotherapy for acute lymphoblastic or undifferentiated leukemia |
| |
ED Kreuser, WD Hetzel, W Heit, D Hoelzer, E Kurrle, N Xiros, and H Heimpel |
| |
JCO Apr 1 1988: 588–595.
[Abstract]
[PDF]
|
|
|
Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease |
| |
S Friedman, M Henry-Amar, JM Cosset, P Carde, M Hayat, N Dupouy, and M Tubiana |
| |
JCO Apr 1 1988: 596–602.
[Abstract]
[PDF]
|
|
|
Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data |
| |
LR Prosnitz, LR Farber, DS Kapp, J Scott, JR Bertino, JJ Fischer, and EC Cadman |
| |
JCO Apr 1 1988: 603–612.
[Abstract]
[PDF]
|
|
|
Psychosocial symptomatology, personal growth, and development among young adult patients following the diagnosis of leukemia or lymphoma |
| |
S Daiter, RA Larson, WW Weddington, and JE Ultmann |
| |
JCO Apr 1 1988: 613–617.
[Abstract]
[PDF]
|
|
|
Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer |
| |
EE Vokes, KE Choi, RL Schilsky, WJ Moran, CM Guarnieri, RR Weichselbaum, and WR Panje |
| |
JCO Apr 1 1988: 618–626.
[Abstract]
[PDF]
|
|
|
Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study |
| |
M Merlano, R Rosso, MR Sertoli, L Bonelli, G Margarino, A Grimaldi, M Benasso, G Gardin, R Corvo, and D Scarpati |
| |
JCO Apr 1 1988: 627–632.
[Abstract]
[PDF]
|
|
|
Chemotherapy can prolong survival in patients with advanced non-small- cell lung cancer--report of a Canadian multicenter randomized trial |
| |
E Rapp, JL Pater, A Willan, Y Cormier, N Murray, WK Evans, DI Hodson, DA Clark, R Feld, and AM Arnold |
| |
JCO Apr 1 1988: 633–641.
[Abstract]
[PDF]
|
|
|
A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial |
| |
Sr Loehrer PJ, S Turner, P Kubilis, S Hui, J Correa, R Ansari, D Stephens, R Woodburn, and S Meyer |
| |
JCO Apr 1 1988: 642–648.
[Abstract]
[PDF]
|
|
|
Preradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors |
| |
JC Allen, R Walker, and G Rosen |
| |
JCO Apr 1 1988: 649–653.
[Abstract]
[PDF]
|
|
|
Tumor response and toxicity after single high-dose versus standard five- day divided-dose dactinomycin in childhood rhabdomyosarcoma |
| |
M Carli, G Pastore, G Perilongo, P Grotto, B De Bernardi, A Ceci, M Di Tullio, E Madon, C Pianca, and G Paolucci |
| |
JCO Apr 1 1988: 654–658.
[Abstract]
[PDF]
|
|
|
Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy |
| |
MG Kris, RJ Gralla, RA Clark, and LB Tyson |
| |
JCO Apr 1 1988: 659–662.
[Abstract]
[PDF]
|
|
|
Control of chemotherapy-induced diarrhea with the synthetic enkephalin BW942C: a randomized trial with placebo in patients receiving cisplatin |
| |
MG Kris, RJ Gralla, RA Clark, LB Tyson, and S Groshen |
| |
JCO Apr 1 1988: 663–668.
[Abstract]
[PDF]
|
|
|
Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation |
| |
JA Thompson, DJ Lee, CG Lindgren, LA Benz, C Collins, D Levitt, and A Fefer |
| |
JCO Apr 1 1988: 669–678.
[Abstract]
[PDF]
|
|
|
A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group |
| |
|
| |
JCO Apr 1 1988: 679–688.
[Abstract]
[PDF]
|
|
|
A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinoma |
| |
R D'Acquisto, M Markman, T Hakes, S Rubin, W Hoskins, and JL Lewis, Jr |
| |
JCO Apr 1 1988: 689–695.
[Abstract]
[PDF]
|
|
|
Phase I/pharmacokinetic study of thioguanine administered as a 48-hour continuous intraperitoneal infusion |
| |
S Zimm, SM Cleary, CN Horton, and SB Howell |
| |
JCO Apr 1 1988: 696–700.
[Abstract]
[PDF]
|
|
|
To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater |
| |
HR Franklin, H Schraffordt Koops, J Oldhoff, BM Czarnetzki, E Macher, BB Kroon, K Welvaart, JW van der Velden, E van Dijk, and EP van der Esch |
| |
JCO Apr 1 1988: 701–708.
[Abstract]
[PDF]
|
|
|
Chemical modifiers of cancer treatment |
| |
CN Coleman, EA Bump, and RA Kramer |
| |
JCO Apr 1 1988: 709–733.
[Abstract]
[PDF]
|
|
|
Clinical stage I carcinoma of the testis: a review |
| |
CY Fung and MB Garnick |
| |
JCO Apr 1 1988: 734–750.
[Abstract]
[PDF]
|
|
| Infusions, age, and drug doses: redux |
| M Coleman and DB Boyd |
|
JCO Apr 1 1988: 751a.
[PDF]
|
|
| Tamoxifen rechallenge |
| P Pronzato, A Ardizzoni, R Lionetto, PF Conte, and R Rosso |
|
JCO Apr 1 1988: 751b–752.
[PDF]
|
|
